Laser ‘Dusting’ Compares Favorably As Kidney Stone Treatment
Technique could reduce the need for ureteral access sheaths.
AUA 2016 Annual Meeting
Cytoreductive RC Aids Survival of Metastatic Bladder Cancer Patients
Patients who underwent debulking had significantly longer overall survival compared with those who did not (median 15.7 vs 10 months).
Patients on Psychiatric Meds Report More Severe OAB Symptoms
These same patients, however, had less intense detrusor overactivity, urodynamic evaluation revealed.
Survival Advantage Confirmed for Nephrectomy in mRCC
About 25% of patients who present with metastatic renal cancer will undergo nephrectomy after diagnosis.
Bariatric Surgery May Ease LUTS in Obese Men
Study documents significant improvements in frequency, urgency, and nocturia.
Cytoreductive Nephrectomy Benefits Select mRCC Patients Taking TT
Among patients treated with targeted therapy, overall survival was 17.1 months for CN recipients vs 7.7 months for those without CN.
Neoadjuvant Chemo Rarely Used in Upper Tract Urothelial Cancer
Therapy used in less than 5% of cases, even in those with higher clinical stage.
PPIs Linked With Higher Rate of Post-RP Complications
Prostate cancer patients taking proton pump inhibitors also had pathologically higher stage disease.
HoLEP Improvements in BPH Symptoms Durable Out to 10 Years
Patients experienced a sustained decrease in AUA Symptom Score, and 95% of patients report being satisfied or very satisfied with the procedure.
Baseline PSA at Age 55-60 Predicts Prostate Cancer Risk
The higher the baseline PSA levels, the greater the risk of being diagnosed with any or significant prostate cancer.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in AUA 2016 Prostate Cancer
Loading... 
Loading...